4//SEC Filing
Berriman John E 4
Accession 0001209191-04-028933
CIK 0001178670other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 6:58 PM ET
Size
10.3 KB
Accession
0001209191-04-028933
Insider Transaction Report
Form 4
Berriman John E
Director
Transactions
- Purchase
Common Stock
2004-05-27$6.00/sh+2,080$12,480→ 2,475 total(indirect: See footnote) - Purchase
Common Stock
2004-05-27$6.00/sh+47,727$286,362→ 56,818 total(indirect: See footnote) - Purchase
Common Stock
2004-05-27$6.00/sh+130,520$783,120→ 155,367 total(indirect: See footnote) - Purchase
Common Stock
2004-05-27$6.00/sh+79,673$478,038→ 94,835 total(indirect: See footnote)
Footnotes (4)
- [F1]These shares were purchased directly by Abingworth BioVentures III A L.P. John E. Berriman is a partner of Abingworth Management Limited, the Manager of Abingworth BioVentures III A L.P.
- [F2]These shares were purchased directly by Abingworth BioVentures III B L.P. John E. Berriman is a partner of Abingworth Management Limited, the Manager of Abingworth BioVentures III B L.P.
- [F3]These shares were purchased directly by Abingworth BioVentures III C L.P. John E. Berriman is a partner of Abingworth Management Limited, the Manager of Abingworth BioVentures III C L.P.
- [F4]These shares were purchased directly by Abingworth BioVentures III Executives L.P. John E. Berriman is a partner of Abingworth Management Limited, the Manager of Abingworth BioVentures III Executives L.P.
Documents
Issuer
ALNYLAM PHARMACEUTICALS INC
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001291964
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 6:58 PM ET
- Size
- 10.3 KB